Who to call at Dogwood Therapeutics, Inc., and when
Fundz watches for the moments Dogwood Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Dogwood Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dogwood Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dogwood Therapeutics, Inc.. With Fundz connected, it knows.
Dogwood Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
dwtx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Dogwood Therapeutics stockholders approved a Second Amended and Restated Equity Incentive Plan that raises the reserved share pool from 191,122 to 2,972,787 shares, and approved potential common stock issuance on conversion of Series A Non-Voting Convertible Preferred Stock at a special meeting held November 21, 2025. The votes also relate to a business combination with Sealbond Limited, so the approvals add near-term dilution and deal-related governance considerations.
Key Takeaways
The equity incentive plan reserve increases by 2,781,665 shares, roughly a 15-fold increase from 191,122 to 2,972,787 shares, which materially expands the company's capacity to grant equity awards.
Stockholders approved the potential issuance of common stock upon conversion of the Series A Non-Voting Convertible Preferred Stock, satisfying Nasdaq Listing Rule 5635 requirements for that issuance.
3 more takeaways
Related Filings (5)
5 more filings from Dogwood Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Dogwood Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.